Stockreport

FDA Approves Aimmune’s PALFORZIA™ as First Treatment for Peanut Allergy

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile
PDF More than 1.6 Million Children and Teens in the U.S. are Allergic to Peanutsi,ii Company to Host Conference Call Today at 5:30 p.m. ET BRISBANE, Calif.--(BUSINESS WIR [Read more]